Kite first telegraphed its plans to tackle viral vector production solo in 2019. The company at the time declined to name its investment in the site or how many employees it aimed to recruit.

Download Theme Although a controversial anime, there is no denying the fantastic animation, tragic story and some of the best action sequences ever put in an anime, that makes Kite one of a kind ...

Kite, a Gilead Company (Nasdaq: GILD), today announced the U.S. Food and Drug Administration (FDA) has approved the company's retroviral vector (RVV) ...